Previous 10 | Next 10 |
AUSTIN, TX and DURHAM, NC, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmu...
2024-01-02 07:18:36 ET Companies mentioned; Siyata Mobile (NASDAQ: SYTA), Aditxt (NASDAQ: ADTX), Cingulate Inc (NASDAQ: CING), C4 Therapeutics Inc. (NASDAQ: CCCC), Merck (NYSE: MRK), and Shattuck Labs (NASDAQ: STTK). DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- Siyata Mobi...
2023-12-29 12:01:47 ET DENVER, Colo., Dec 29, 2023 ( www.247marketnews.com )- Aditxt Inc. (NASDAQ: ADTX), Cingulate Inc (NASDAQ: CING), C4 Therapeutics Inc. (NASDAQ: CCCC), Shattuck Labs (NASDAQ: STTK), Siyata Mobile (NASDAQ: SYTA), Sentage Holdings Inc (NASDAQ: SNTG), and Merck (NYSE: ...
2023-12-27 16:50:08 ET DENVER, Colo., Dec. 27, 2023 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; First Wave BioPharma (NASDAQ: FWBI), TeraWulf (NASDAQ: WULF), Bit Digital Inc (NASDAQ: BTBT), Wheels Up Experience (NYSE: UP), Shattuck Labs (NASDAQ: ST...
2023-12-21 18:58:17 ET Summary Positive results were released from the phase 1A/B study, using SL-172154 in combination with azacitidine for the treatment of patients with front-line higher-risk myelodysplastic syndrome and TP53 mutant acute myeloid leukemia. Additional results fr...
2023-12-21 08:11:43 ET More on Shattuck Labs Shattuck Labs: Early Positive Data May Be A Harbinger Of Good Things Shattuck Labs, Inc. (STTK) Q3 2023 Earnings Call Transcript Shattuck Labs, Inc. 2023 Q3 - Results - Earnings Call Presentation Shattuck Labs stoc...
AUSTIN, TX and DURHAM, NC, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the...
2023-12-18 18:28:50 ET Summary Shattuck Labs develops bi-functional fusion proteins for cancer and autoimmune diseases, with over 400 drug candidates. Their primary clinical-stage product, SL-172154, showed positive results in Phase 1 trials for ovarian cancer and hematologic mali...
2023-12-14 12:33:59 ET DENVER, Colo., Dec. 14, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Freight Technologies Inc (NASDAQ: FRGT), C4 Therapeutics Inc. (NASDAQ: CCCC), Shattuck Labs Inc (NASDA...
2023-12-14 12:28:56 ET Gainers: Freight Technologies ( FRGT ) +178% . TPI Composites ( TPIC ) +67% . TriSalus Life Sciences ( TLSI ) +35% . Codexis ( CDXS ) +33% . Canterbury Park Holding Corp ( CPHC ) +33% . Canaan ( CAN ...
News, Short Squeeze, Breakout and More Instantly...
Shattuck Labs Inc. Company Name:
STTK Stock Symbol:
NASDAQ Market:
– Observed encouraging complete response (CR) rates as of the February 1, 2024, data cutoff in previously untreated HR-MDS and TP53m AML patients; successfully bridged responding TP53m AML patients to hematopoietic cell transplantation – – SL-172154 continued t...
- Completed additional enrollment in Phase 1B dose-expansion cohorts for TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) patients in the first quarter of 2024; updated combination data expected at the European Society of Hematology (EHA) 2024 Annual Meeting in June – - Randomized,...
2024-04-16 19:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...